MicroRNAs as biomarkers for myocardial infarction

43Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MicroRNAs (miRs) are short non-coding RNA molecules involved in post-transcriptional gene regulation by binding to the 3' untranslated region of a messenger RNA (mRNA), thereby inhibiting the translation or inducing mRNA destabilization. MiRs are generally considered to act as intracellular mediators essential for normal cardiac function, and their deregulated expression profiles have been associated with cardiovascular diseases. Recent studies have revealed the existence of freely circulating miRs in human peripheral blood, which are present in a stable nature. This has raised the possibility that miRs may be released in the circulation and can serve as novel diagnostic markers for acute or chronic human disorders, including myocardial infarction (MI). This review summarizes the recent findings of miRs that fulfill the criteria of candidate biomarkers for MI. © The Author(s) 2012.

Cite

CITATION STYLE

APA

Salic, K., & De Windt, L. J. (2012). MicroRNAs as biomarkers for myocardial infarction. Current Atherosclerosis Reports, 14(3), 193–200. https://doi.org/10.1007/s11883-012-0238-z

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free